Europe · Wires & real time · MarketScreener

argenx SE Stock

Published by MarketScreener · France 8 h ago

Oct. 19 Argenx SE Announces Phase 3 ALKIVIA Results In Autoimmune Myositis As Late-Breaking Oral Presentation At ACR Convergence 2026 CI ...

Read the full article on MarketScreener Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketscreener.com)

Also worth reading

American national signs contract with Russian Defense Ministry’s Akhmat commando unit

UK labor market sees flat trend, employment rate rises

Reuters Technology

Google Cloud services experience outage in Europe

As France erupts, Europe's far right gains from fuel-price anger ahead of elections

Reuters Business

EssilorLuxottica's smart glasses boom runs into tougher regulatory scrutiny

Reuters Breakingviews

Boaz Weinstein’s UK feud tests watchdog's bite